Vincent See, MD, electrophysiologist, as well as Murtaza Dawood, MD, cardiac surgeon, discuss how procedures like the Watchman™ device implantation are helping to prevent stroke in afib patients. By closing off the LAA, a thin, sack-like appendix arising from the left side of the heart that is believed to be the source of a majority of stroke-causing blood clots in people with non-valvular afib, the risk of stroke may be reduced and, over time, patients may be able to stop taking warfarin. Implantation is a one-time procedure that usually lasts about an hour.
Specific indications for the Watchman™ include:
• CHADS2 2 or CHA2DS2-VASc 3
• Relative contraindication to long-term AC
• Ability to tolerate short-term AC (45 days) with Coumadin following implant
Patients with afib have a five-fold increased risk of stroke and many therapies are systemic in nature requiring a multi-disciplinary approach to treatment. For more information or to refer a patient to University of Maryland Heart & Vascular Center, call 410-328-6056.
REFER A PATIENT
Call 410-328-6056, download the UMMC MD Referral App or learn more.
FDA Watchman™ Overview
Learn more about atrial fibrillation at University of Maryland